Anxo Pharmaceutical Co (ROCO:6677) Long-Term Debt : NT$456.6 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co Long-Term Debt?

Anxo Pharmaceutical Co's Long-Term Debt for the quarter that ended in Jun. 2024 was NT$456.6 Mil.

Anxo Pharmaceutical Co's quarterly Long-Term Debt declined from Jun. 2023 (NT$504.1 Mil) to Dec. 2023 (NT$480.7 Mil) and declined from Dec. 2023 (NT$480.7 Mil) to Jun. 2024 (NT$456.6 Mil).

Anxo Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (NT$572.6 Mil) to Dec. 2022 (NT$528.1 Mil) and declined from Dec. 2022 (NT$528.1 Mil) to Dec. 2023 (NT$480.7 Mil).

Anxo Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Anxo Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co Long-Term Debt Chart

Anxo Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

663.48

622.25

572.61

528.08

480.70

Anxo Pharmaceutical Co Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial														548.14	528.08	504.08	480.70	456.61

Anxo Pharmaceutical Co (ROCO:6677) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Anxo Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Anxo Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN

Website

http://www.anxo.com.tw

Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co Headlines

No Headlines